Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Construction in Progress (2023 - 2025)

Organogenesis Holdings (ORGO) has 3 years of Construction in Progress data on record, last reported at $26.7 million in Q4 2025.

  • For Q4 2025, Construction in Progress rose 22.19% year-over-year to $26.7 million; the TTM value through Dec 2025 reached $26.7 million, up 22.19%, while the annual FY2025 figure was $26.7 million, 22.19% up from the prior year.
  • Construction in Progress reached $26.7 million in Q4 2025 per ORGO's latest filing, down from $27.5 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $59.1 million in Q4 2023 and bottomed at $20.6 million in Q3 2024.
  • Average Construction in Progress over 3 years is $29.1 million, with a median of $23.9 million recorded in 2025.
  • Peak YoY movement for Construction in Progress: crashed 62.95% in 2024, then skyrocketed 33.66% in 2025.
  • A 3-year view of Construction in Progress shows it stood at $59.1 million in 2023, then plummeted by 62.95% to $21.9 million in 2024, then increased by 22.19% to $26.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Construction in Progress were $26.7 million in Q4 2025, $27.5 million in Q3 2025, and $23.9 million in Q2 2025.